CHEK2 and breast carcinoma: Overall, germline BRCA1 mutated cancers had significantly higher cyclin E1 protein than the BRCA1 wildtype cases, and tumors with other breast cancer associated germline mutations (BRCA2, PALB2, or CHEK2) (Fig. 1b).